174 related articles for article (PubMed ID: 15734958)
1. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
Martínez-Ramírez OC; Pérez-Morales R; Castro C; Flores-Díaz A; Soto-Cruz KE; Astorga-Ramos A; Gonsebatt ME; Casas L; Valdés-Flores M; Rubio J
Breast; 2013 Jun; 22(3):335-43. PubMed ID: 23000097
[TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
[TBL] [Abstract][Full Text] [Related]
8. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
[TBL] [Abstract][Full Text] [Related]
10. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
12. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].
Zimarina TC; Kristensen VN; Imianitov EN; Bershteĭn LM
Mol Biol (Mosk); 2004; 38(3):386-93. PubMed ID: 15285606
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
14. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
[TBL] [Abstract][Full Text] [Related]
16. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
17. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
19. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
